MedTrace Logo

Prevention of Rabies With Four Doses of Rabies Vaccine

NCT05545371 · Status: ENROLLING_BY_INVITATION · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2024-07-10

No results posted yet for this study

Summary

To evaluate the non inferiority of the immunogenicity of the test vaccine inoculated according to the four dose immunization program over the five dose immunization program and the batches consistency of immunogenicity according to five dose immunization procedures.

Conditions

  • Rabies Human
  • Antibody

Interventions

BIOLOGICAL

immunization procedures

The subjects were vaccinated with rabies vaccine according to different immunization procedures

Sponsors & Collaborators

  • Changchun Zhuoyi Biological Co., Ltd

    lead OTHER

Principal Investigators

  • Li Miao · Changchun Zhuoyi Biological Co., Ltd

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-18
Primary Completion
2024-11-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05545371 on ClinicalTrials.gov